Workflow
System which identifies patients at risk of fatal heart attack obtains CE mark.
Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.
Companies will shed light on immunotherapy, an emerging therapeutic approach that helps the immune system fight cancer, in a brand-new study on one of the most impacting cancers worldwide.